Home > Balance Sheet > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Balance Sheet

SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Balance Sheet History

[Consolidated]

Mar2024Mar2023
EQUITY AND LIABILITIES
Share Capital ₹32 Cr₹32 Cr
    Equity - Authorised ₹43 Cr₹43 Cr
    Equity - Issued ₹32 Cr₹32 Cr
    Equity Paid Up ₹32 Cr₹32 Cr
    Equity Shares Forfeited --
    Adjustments to Equity --
    Preference Capital Paid Up --
    Face Value ₹1.00₹1.00
Share Warrants & Outstandings --
Total Reserves ₹93 Cr₹480 Cr
    Securities Premium ₹2,038 Cr₹2,038 Cr
    Capital Reserves --
    Profit & Loss Account Balance ₹-1,979 Cr₹-1,592 Cr
    General Reserves ₹34 Cr₹34 Cr
    Other Reserves ₹0.01 Cr-
Reserve excluding Revaluation Reserve ₹93 Cr₹480 Cr
Revaluation reserve --
Shareholder's Funds ₹126 Cr₹513 Cr
Minority Interest --
Long-Term Borrowings --
Secured Loans --
    Non Convertible Debentures --
    Converible Debentures & Bonds --
    Packing Credit - Bank --
    Inter Corporate & Security Deposit --
    Term Loans - Banks --
    Term Loans - Institutions --
    Other Secured --
Unsecured Loans --
    Fixed Deposits - Public --
    Loans and advances from subsidiaries --
    Inter Corporate Deposits (Unsecured) --
    Foreign Currency Convertible Notes --
    Long Term Loan in Foreign Currency --
    Loans - Banks --
    Loans - Govt. --
    Loans - Others --
    Other Unsecured Loan --
Deferred Tax Assets / Liabilities ₹-1.26 Cr-
    Deferred Tax Assets ₹30 Cr₹28 Cr
    Deferred Tax Liability ₹28 Cr₹28 Cr
Other Long Term Liabilities ₹118 Cr₹130 Cr
Long Term Trade Payables --
Long Term Provisions ₹6.05 Cr₹8.14 Cr
Total Non-Current Liabilities ₹123 Cr₹138 Cr
Current Liabilities --
Trade Payables ₹142 Cr₹148 Cr
    Sundry Creditors ₹142 Cr₹148 Cr
    Acceptances --
    Due to Subsidiaries- Trade Payables --
Other Current Liabilities ₹62 Cr₹24 Cr
    Bank Overdraft / Short term credit --
    Advances received from customers -₹0.00 Cr
    Interest Accrued But Not Due ₹0.07 Cr-
    Share Application Money -₹0.00 Cr
    Current maturity of Debentures & Bonds --
    Current maturity - Others --
    Other Liabilities ₹62 Cr₹24 Cr
Short Term Borrowings ₹47 Cr₹0.05 Cr
    Secured ST Loans repayable on Demands ₹47 Cr₹0.05 Cr
    Working Capital Loans- Sec ₹47 Cr₹0.05 Cr
    Buyers Credits - Unsec --
    Commercial Borrowings- Unsec --
    Other Unsecured Loans ₹-47 Cr₹-0.05 Cr
Short Term Provisions ₹14 Cr₹6.49 Cr
    Proposed Equity Dividend --
    Provision for Corporate Dividend Tax --
    Provision for Tax ₹1.65 Cr-
    Provision for post retirement benefits --
    Preference Dividend --
    Other Provisions ₹12 Cr₹6.49 Cr
Total Current Liabilities ₹265 Cr₹179 Cr
Total Liabilities ₹514 Cr₹830 Cr
ASSETS
Gross Block ₹157 Cr₹146 Cr
Less: Accumulated Depreciation ₹50 Cr₹40 Cr
Less: Impairment of Assets --
Net Block ₹108 Cr₹106 Cr
Lease Adjustment A/c --
Capital Work in Progress ₹1.27 Cr₹1.87 Cr
Non Current Investments --
Long Term Investment --
    Quoted --
    Unquoted --
Long Term Loans & Advances ₹68 Cr₹65 Cr
Other Non Current Assets ₹25 Cr₹178 Cr
Total Non-Current Assets ₹244 Cr₹375 Cr
Current Assets Loans & Advances --
Currents Investments ₹1.80 Cr₹291 Cr
    Quoted ₹1.80 Cr₹96 Cr
    Unquoted -₹195 Cr
Inventories --
    Raw Materials --
    Work-in Progress --
    Finished Goods --
    Packing Materials --
    Stores  and Spare --
    Other Inventory --
Sundry Debtors ₹16 Cr₹33 Cr
    Debtors more than Six months ₹6.55 Cr-
    Debtors Others ₹11 Cr₹33 Cr
Cash and Bank ₹155 Cr₹112 Cr
    Cash in hand ₹0.00 Cr₹0.00 Cr
    Balances at Bank ₹155 Cr₹112 Cr
    Other cash and bank balances --
Other Current Assets ₹42 Cr₹3.98 Cr
    Interest accrued on Investments ₹14 Cr₹0.63 Cr
    Interest accrued on Debentures --
    Deposits with Government --
    Interest accrued and or due on loans --
    Prepaid Expenses ₹4.82 Cr₹3.33 Cr
    Other current_assets ₹23 Cr₹0.02 Cr
Short Term Loans and Advances ₹54 Cr₹16 Cr
    Advances recoverable in cash or in kind ₹4.35 Cr₹4.58 Cr
    Advance income tax and TDS --
    Amounts due from directors --
    Due From Subsidiaries --
    Inter corporate deposits --
    Corporate Deposits --
    Other Loans & Advances ₹50 Cr₹11 Cr
Total Current Assets ₹269 Cr₹455 Cr
Net Current Assets (Including Current Investments) ₹4.33 Cr₹276 Cr
Miscellaneous Expenses not written off --
Total Assets ₹514 Cr₹830 Cr
Contingent Liabilities ₹84 Cr₹84 Cr
Total Debt ₹47 Cr₹0.05 Cr
Book Value 3.8815.80
Adjusted Book Value 3.8815.80

Compare Balance Sheet of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹4,854.5 Cr -2.1% 1.3% -51.1% Stock Analytics
SYNGENE INTERNATIONAL ₹25,345.7 Cr -13.1% -12% -7.2% Stock Analytics
SAGILITY INDIA ₹19,141.9 Cr -5.3% -5.7% NA Stock Analytics
LATENT VIEW ANALYTICS ₹8,328.0 Cr 1.8% 5.9% -18.2% Stock Analytics
JUST DIAL ₹7,850.7 Cr -10.3% 6.4% -12.2% Stock Analytics
AWFIS SPACE SOLUTIONS ₹4,678.2 Cr 0.2% 6.6% NA Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-2.1%

1.3%

-51.1%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses